BioSpace News Archive

Drug Development

Study Suggests Late Stage Asset Lecanemab Could Delay Progression of Alzheimer’s Dementia

New research suggests that treatment with anti-amyloid-beta protofibril antibody lecanemab is estimated to slow the rate of disease progression in patients with Alzheimer’s Disease.

April 27, 2022
·
2 min read
·
Hayley Shasteen
Policy

Ousted Whitehead Institute Researcher David Sabatini Up for Position at NYU

David Sabatini, who was ousted last year by the Whitehead Institute over allegations of sexual harassment, may have found a new home at the NYU Grossman School of Medicine.

April 27, 2022
·
3 min read
·
Alex Keown
Business

Cytovia Goes Public in SPAC Deal Amidst Slow Biotech IPO Environment

Cytovia Holdings, a biopharma company focused on natural killer (NK) cells, merged with special purpose acquisition company (SPAC) Isleworth Healthcare Acquisition Corp. to go public.

April 27, 2022
·
3 min read
·
Mark Terry
Microbiologics Acquires Cryologics

Microbiologics, Inc. the foremost provider of biomaterials and contract microbiology research services, is pleased to announce the acquisition of Cryologics

April 27, 2022
·
2 min read
Policy

Following Gilead’s Lead, J&J Takes Action Against Counterfeit HIV Drugs

Weeks after Gilead Sciences raised concern over counterfeit HIV drugs, Johnson & Johnson has taken similar action against the distribution of counterfeit prescription drugs.

April 27, 2022
·
2 min read
·
Mark Terry
Drug Development

BeiGene, Novartis Drug Tislelizumab Demonstrates Strong Survival Benefit in Esophageal Cancer

BeiGene’s candidate drug tislelizumab for cancer succeeded in meeting the primary endpoint of overall survival in a global Phase III trial. Learn more about it here.

April 27, 2022
·
2 min read
·
Vanessa Doctor, RN
FDA

AviadoBio’s FTD Therapeutic Scores FDA, EC Orphan Drug Designation

AviadoBio is celebrating orphan drug designations from both the U.S. FDA and the European Commission for AVB-101, a gene therapy intended to treat frontotemporal dementia (FTD).

April 27, 2022
·
2 min read
·
Jazmine Colatriano, M.S.
Business

Global Roundup: Exogene Secures Funding to Support TCR Discovery

Exogene nets $2 million to propel the development of its AI platform for T-cell receptor discovery and Healome spins out to deploy a ‘pro-healing’ platform with a focus on ocular surface diseases.

April 27, 2022
·
7 min read
·
Alex Keown
Hepatitis Diagnostic Test Market Analysis 2022-2028- Growing Burden Of Hepatitis Diseases And Rising Number Of Blood Donation And Blood Transfusion

Rising awareness about hepatitis symptoms and growing need for early diagnosis through public education and increasing occurrence of hepatitis across the globe are fueling global market growth.

April 27, 2022
·
7 min read
Business

Amgen Battles IRS Over Billions in “Wholly Unwarranted” Tax Penalties

Amgen held its earnings conference call on Wednesday for Q1 of 2022. Most notably, the company provided updates on its ongoing litigation with the Internal Revenue Service.

April 27, 2022
·
2 min read
·
Rosemary Scott